The Effects of Natesto For Treatment Of Hypogonadism On Maintenance Of Spermatogensis.
Latest Information Update: 29 Apr 2024
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 22 Apr 2024 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 09 May 2023 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 09 May 2023 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2024.